Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07B
- Chemical subgroupJ07BC
- Chemical substanceJ07BC01Hepatitis b, purified antigen
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 14 registrations
- Engerix-B10 MCG / 0.5 ML · Suspension · Glaxosmithkline INC
- Engerix-B20 MCG / 1 ML · Suspension · Glaxosmithkline INC
- Recombivax HB10 MCG / 1 ML · Solution · Merck Canada INC
- Recombivax HB40 MCG / ML · Suspension · Merck Canada INC
Singapore
HSA · 5 registrations
At a glance
- ATC code
- J07BC01
- ATC group
- Anti-infectives for systemic use
- Registers
- 4
- Registrations
- 22
- With their own page
- 15
- Companies
- 8
All medicines with Hepatitis b surface antigen
Human medicines from every register that match Hepatitis b surface antigen by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
37 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Heplisav B | European Union | Authorised | Dynavax GmbH | ||
| Engerix-B | Canada | 20 MCG / 1 ML | Suspension | Marketed | Glaxosmithkline INC |
| Engerix-B | Canada | 10 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Infanrix HexaCombination | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Recombivax HB | Canada | 10 MCG / 1 ML | Solution | Marketed | Merck Canada INC |
| Recombivax HB | Canada | 40 MCG / ML | Suspension | Marketed | Merck Canada INC |
| Recombivax HB | Canada | 5 MCG / 0.5 ML | Solution | Marketed | Merck Canada INC |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| TwinrixCombination | Canada | 720 UNIT / 1 ML + 20 MCG / 1 ML | Suspension | Marketed | Glaxosmithkline INC |
| Twinrix JuniorCombination | Canada | 360 UNIT / 0.5 ML + 10 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Engerix-B Suspension for Injection in Prefilled Syringe 20MCG/ML | Singapore | 20 mcg/mL | injection, suspension | Authorised | Glaxosmithkline Pte LTD |
| ENGERIX-B SUSPENSION FOR INJECTION IN PREFILLED SYRINGE 10mcg/0.5ml | Singapore | 10 mcg/0.5ml | injection, suspension | Authorised | Glaxosmithkline Pte LTD |
| Infanrix Hexa VaccineCombination | Singapore | min 30 iu/0.5 ml + 25 mcg/0.5 ml + 10 mcg/0.5 ml + 10 mcg/0.5 ml + 8 mcg/0.5 ml + 25 mcg/0.5 ml + 40 du/0.5 ml + 8 du/0.5 ml + 32 du/0.5 ml + min 40 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Prehevbrio | Canada | 10 MCG / ML | Suspension | Authorised | Vbi Vaccines INC. |
| Twinrix VaccineCombination | Singapore | 720 elisa units/ml + 20 mcg/ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Engerix-B | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Engerix B | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Engerix B 20 | Saudi Arabia | Authorised | GlaxoSmithKline Biologicals | ||
| Hexaxim VaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur SA | ||
| HEXAXIM vaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| HEXAXIM vaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Euvax B 10MCG Vial | Saudi Arabia | Authorised | LG Chem , Osong Plant | ||
| Euvax B 20MCG Vial | Saudi Arabia | Authorised | LG Chem , Osong Plant | ||
| Infanrix Hexa VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Twinrix Adult Monodose Preflled SyringeCombination | Saudi Arabia | Authorised | Glaxowellcome |